Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
149.9 USD | +0.53% | +3.88% | -4.26% |
Apr. 22 | J&J: EU green light for Carvykti in multiple myeloma | CF |
Apr. 22 | Daiwa Securities Adjusts Johnson & Johnson's Price Target to $160 From $170, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.26% | 359B | |
+27.88% | 659B | |
+27.68% | 557B | |
+16.46% | 322B | |
+9.09% | 297B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.61% | 149B | |
-4.81% | 146B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson : UBS Adjusts Price Target on Johnson & Johnson to $170 From $160, Maintains Neutral Rating